Compounds > garenoxacin
Page last updated: 2024-09-03

garenoxacin and Disease Models, Animal

garenoxacin has been researched along with Disease Models, Animal in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daw-Garza, A; Lozano-Garza, HG; Ocampo-Candiani, J; Rocha, NC; Said-Fernández, S; Vera-Cabrera, L; Waksman de Torres, N; Welsh, O1
Fukuda, Y; Furuya, Y; Mitsuyama, J; Nomura, N; Nozaki, Y; Takahata, M1
Fukuda, Y; Futakuchi, N; Mitsuyama, J; Nomura, N; Shiokawa, Y; Sugiura, Y; Takahata, M1
Banevicius, M; Mattoes, HM; Nicolau, DP; Nightingale, CH; Xuan, D1
Edelstein, MA; Edelstein, PH; Shinzato, T1
Acosta, F; Cottagnoud, M; Cottagnoud, P; Pfister, M; Täuber, MG1

Other Studies

6 other study(ies) available for garenoxacin and Disease Models, Animal

ArticleYear
In vivo therapeutic effect of gatifloxacin on BALB/c mice infected with Nocardia brasiliensis.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Mice; Mice, Inbred BALB C; Nocardia; Nocardia Infections; Oxazolidinones; Treatment Outcome

2008
Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection.
    Diagnostic microbiology and infectious disease, 2014, Volume: 78, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Coinfection; Disease Models, Animal; Female; Fluoroquinolones; Influenza A virus; Lung; Mice; Orthomyxoviridae Infections; Pneumonia, Pneumococcal; Respiratory Mucosa; Streptococcus pneumoniae

2014
In vitro and in vivo antibacterial activities of garenoxacin against group G Streptococcus dysgalactiae subsp. equisimilis.
    International journal of antimicrobial agents, 2011, Volume: 38, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Fluoroquinolones; Humans; Male; Mice; Microbial Sensitivity Tests; Pneumonia, Bacterial; Streptococcal Infections; Streptococcus; Treatment Outcome

2011
Pharmacodynamics of a novel des-F(6)-quinolone, BMS-284756, against Streptococcus pneumoniae in the thigh infection model.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:5

    Topics: Animals; Anti-Infective Agents; Area Under Curve; Disease Models, Animal; Fluoroquinolones; Indoles; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumococcal Infections; Protein Binding; Quinolones; Streptococcus pneumoniae; Thigh

2003
BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:5

    Topics: Animals; Anti-Infective Agents; Culture Media; Disease Models, Animal; Fluoroquinolones; Guinea Pigs; Indoles; Legionella pneumophila; Legionnaires' Disease; Male; Quinolones

2001
Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:1

    Topics: 4-Quinolones; Animals; Anti-Infective Agents; Disease Models, Animal; Fluoroquinolones; Indoles; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rabbits; Streptococcus pneumoniae; Treatment Outcome

2002